☰

Ibrahim Aljuffali - Publications

Affiliations: 
2006-2010 Pharmaceutical and Biomedical Sciences University of Georgia, Athens, Athens, GA, United States 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Aljuffali IA, Anwer MK, Ahmed MM, Alalaiwe A, Aldawsari MF, Fatima F, Jamil S. Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells. Pharmaceuticals (Basel, Switzerland). 16. PMID 38004415 DOI: 10.3390/ph16111549  0.621
2023 Anwer MK, Ahmed MM, Aldawsari MF, Iqbal M, Soliman GA, Aljuffali IA. Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box-Behnken Design, and Anti-Diarrheal Activity. Pharmaceutics. 15. PMID 37242700 DOI: 10.3390/pharmaceutics15051460  0.596
2016 Aljuffali IA, Fang CL, Chen CH, Fang JY. Nanomedicine as a strategy for natural compound delivery to prevent and treat cancers. Current Pharmaceutical Design. PMID 27323758  0.302
2015 Kang JY, Eggert M, Mouli S, Aljuffali I, Fu X, Nie B, Sheil A, Waddey K, Oldham CD, May SW, Amin R, Arnold RD. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models. Pharmaceutical Research. 32: 852-62. PMID 25158648 DOI: 10.1007/S11095-014-1501-5  0.611
2012 Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD. Pharmacokinetic assessment of ketanserin in the horse. Journal of Veterinary Pharmacology and Therapeutics. 35: 472-7. PMID 22091605 DOI: 10.1111/J.1365-2885.2011.01346.X  0.466
2011 Aljuffali IA, Mock JN, Costyn LJ, Nguyen H, Nagy T, Cummings BS, Arnold RD. Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer. Cancer Biology & Therapy. 12: 407-20. PMID 21709443 DOI: 10.4161/Cbt.12.5.15950  0.649
2011 Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A 2 responsive liposomes Journal of Pharmaceutical Sciences. 100: 3146-3159. PMID 21455978 DOI: 10.1002/Jps.22530  0.608
2010 Aljuffali I, Brainard B, Moore J, Allen D, Robertson T, Arnold R. Pharmacokinetics and Pharmacodynamics of Ketanserin Journal of Equine Veterinary Science. 30: 103-104. DOI: 10.1016/J.Jevs.2010.01.021  0.465
Show low-probability matches.